Zymergen–ZY-NYSE – went public in early May 2021 via IPO led by Goldman Sachs and JP Morgan at $30 per share. It dutifully rose to
We are excited to share the first episode of Compounders: The Anatomy of a Multibagger. In this brief episode, Ben Claremon discusses why we decided
It is difficult to see how this is an isolated instance. Be long corporate Paddy Wagons.
It is not crazy to suggest that the Covid Transition Period – CTP – might have disrupted normalized studying and test-taking protocol. On the other
Thanks to my budding relationship with SNN Network CEO, Bobby Kraft, I have been asked to be a keynote speaker at the upcoming Summer Virtual
As previously noted in our previous CSC blog on Exxon: Indexing highly liquid assets and managing them as a fiduciary at a very low cost
Cove Street is pleased to announce that its new podcast, Compounders: The Anatomy of a Multibagger, will officially be launched on August 3rd. The podcast
Original article appeared in Harvard Business School’s Working Knowledge What Does an ESG Score Really Say About a Company? 21 JUL 2021|by Kristen Senz A
This is a “Letter From the Founders” culled from the S-1 of Lemonade (LMND) – a recent IPO we took a shot at a few
It is popular in some circles to suggest that in a passive world, “no one will care about Small Cap stocks and thus a value
Our lead principal and Portfolio Manager Jeffrey Bronchick, CFA was asked to do an interview with Ross Roggensack of Oak City Consulting. Sartorial choices aside,
The following is an excerpt from our Q3 2020 Small Cap Plus letter. If you have ever found yourself struggling to explain why, in the
From Billion Dollar Loser, the new book chronicling the WeWork disaster: As one member of WeWork’s finance team put it: “The nature of private markets
What is the actual float of a company? How many shares are actually tradeable relative to the headline free float share count that major data
As we have noted in this space in the past, “these dudes” have been more than mostly right for a really long time on what
Value Losses Lead $10 Billion Quant Trader AJO Partners to Shut: AJO Partners, a $10 billion quantitative fund manager, will shut by the end of
Musings on Markets: Sounding good or Doing good? A Skeptical Look at ESG.
Most of the time when I am espousing the Cove Street gospel in the podcast realm, the audience consists of a bunch of people with
Never in the history of the world have more people had more access to information. And yet… On My Mind: They Blinded Us From Science
One of the more difficult parts of my job is to essentially say the same thing in novel ways in order to keep clients, listeners,
A very long time ago, the author was the first outside columnist for TheStreet.com, which in its early days had a terrific set of people
So imagine you are on one of those innumerable TV cop shows where apparently if you stick a variety of crime scene photos on a
An extraordinarily cogent narrative of why this is our largest position. He almost had us until the Buffett and Graham part. Worth reading twice end
Early in my career, I would saddle up the horse and carriage, go to the office, call a company of interest and ask for them
In a world that loves data and quantification no matter what the source or the possibility of reaching a bewildering machine learned conclusion that makes
This study should either seem obvious and not worth reading past the summary; or it should seem obvious and therefore Elizabeth Warren is the obvious
Swimming against the prevailing investment tide is often fairly difficult. Humans by their nature feel safer in the crowd and standing out from said crowd
From Charlie Ergen’s Q2 SATS Conference Call: “So it’s an interesting time. I think patience — I hope our patience will be rewarded. It hasn’t
Did Lockdown Work? An Economist’s Cross-Country Comparison by Christian Bjornskov
Observation: If something cannot go forever, it won’t. At current performance rates, there will be five stocks comprising 110% of US market cap. That “seems”
